Paper Details

  1. Home
  2. Paper Details

Darifenacin for the treatment of overactive bladder.

Author: HaabFrançois

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Darifenacin is a selective muscarinic M(3) receptor antagonist for overactive bladder. It improves symptoms such as urgency, urge incontinence and frequency while reducing side effects associated with non-M(3) muscarinic receptor antagonism in the brain or heart. Darifenacin is effective and safe, offering an alternative approach to treating overactive bladder.
Paper Details　
Original Abstract of the Article :
Overactive bladder is a debilitating disorder affecting 16.5% of adults and increasing in prevalence with age. Symptoms, including urgency, urge incontinence and frequency can result from detrusor overactivity with contraction of the bladder mediated primarily by activation of muscarinic M(3) recept...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2217/17455057.1.3.331

データ提供：米国国立医学図書館（NLM）

Darifenacin: A New Oasis in the Desert of Overactive Bladder Treatment

This research explores the potential of darifenacin, a selective muscarinic M(3) receptor antagonist, for the treatment of overactive bladder (OAB). The researchers, like explorers navigating a vast desert of OAB treatment options, sought to develop a more targeted and effective therapy. Their findings, like a refreshing oasis in the desert, highlight the potential benefits of darifenacin in alleviating OAB symptoms. The study demonstrated that darifenacin effectively reduces OAB symptoms, such as urgency, frequency, and incontinence, while minimizing the side effects commonly associated with other antimuscarinic agents.

A More Targeted Approach to Overactive Bladder Treatment

This research offers a promising new approach to OAB treatment. The study's findings, like a shimmering mirage in the desert, suggest that darifenacin, with its selective targeting of M(3) receptors, could offer a more effective and well-tolerated treatment option for individuals with OAB. This discovery could significantly improve the quality of life for those struggling with this debilitating condition.

Understanding Overactive Bladder and its Treatment

Understanding the underlying mechanisms of OAB and the potential benefits of darifenacin is crucial for developing effective treatment strategies. The research highlights the importance of developing more targeted therapies that address the specific causes of OAB symptoms. This approach can lead to more effective treatments and improved outcomes for patients.

Dr. Camel's Conclusion

This research, like a camel caravan traversing the desert of overactive bladder treatment, reveals a promising new oasis. The findings suggest that darifenacin, with its selective targeting of M(3) receptors, could offer a more effective and well-tolerated treatment option for individuals with OAB. This discovery holds promise for improving the quality of life for those struggling with this debilitating condition.
Date :
  1. Date Completed 2012-10-02
  2. Date Revised 2016-07-01
Further Info :

Pubmed ID

19803875

DOI: Digital Object Identifier

10.2217/17455057.1.3.331

Related Literature

Article Analysis
・Side Effects of darifenacin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.